IP Library Granted Patent US 9,868,754
Granted Patent B2
US 9,868,754 · App. 14/237,795 · Granted Jan 16, 2018

Utility of nematode small molecules

Inventors: Andrea Choe (Pasadena, CA); Paul W. Sternberg (San Marino, CA); Frank C. Schroeder (Ithaca, NY); Stephan H. Von Reuss (Jena, DE)
Assignees: California Institute of Technology; Boyce Thompson Institute for Plant Research
C07H15/04A01N37/36A01N43/16A01N43/38A01N63/02A61K31/454A61K31/7028C07H15/08C07H15/10C07H15/18C07H15/26C07D309/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,868,754
App. No.
14/237,795
Granted
Jan 16, 2018
Kind
B2
Abstract

The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. In one embodiment, the present invention provides a method of treating an immune and inflammatory disorders disorder by administering a composition comprising a therapeutically effective dosage of an ascaroside compound, or a mixture of ascaroside compounds, or a mixture containing at least one ascaroside.

Claims (9)

1. A method of alleviating or treating an inflammatory disorder in a human subject, comprising:

administering to the subject a composition comprising isolated ascr#7

or a salt thereof; and

wherein the inflammatory disorder is asthma, inflammatory bowel disease, or type one diabetes.

2. The method of claim 1 , wherein the method reduces mucus production in the subject.

3. The method of claim 1 , wherein the naturally occurring ascaroside is produced from a Nippostrongylus brasiliensis.

4. The method of claim 1 , wherein the inflammatory disorder is asthma.

5. The method of claim 1 , wherein the inflammatory disorder is inflammatory bowel disease.

6. The method of claim 1 , wherein the inflammatory disorder is type one diabetes.

Assignments (4)
CONFIRMATORY LICENSE Recorded Feb 4, 2021
From: BOYCE THOMPSON INST FOR PLANT RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 055222/0620 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2017
From: VON REUSS, STEPHAN HEINRICH
To: BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH
Reel/Frame 044671/0912 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2014
From: CHOE, ANDREA; STERNBERG, PAUL WARREN
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 032998/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2014
From: SCHROEDER, FRANK C.
To: BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH
Reel/Frame 033071/0907 →
Continuity (5)
Provisional Application 61620348 · Apr 4, 2012
Provisional Application 61620331 · Apr 4, 2012
Provisional Application 61620343 · Apr 4, 2012
Provisional Application 61521295 · Aug 8, 2011
Related Publication 20150018291A1 · Jan 15, 2015